Fabrice Chrétien

820 total citations
17 papers, 371 citations indexed

About

Fabrice Chrétien is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Fabrice Chrétien has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 8 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Fabrice Chrétien's work include Glioma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Fabrice Chrétien is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Fabrice Chrétien collaborates with scholars based in France, United States and United Kingdom. Fabrice Chrétien's co-authors include Françoise Gray, Pascale Varlet, Karima Mokhtari, Johan Pallud, Catherine Oppenheim, Marc Polivka, Laurent Capelle, Edouard Dezamis, Grégory Kuchcinski and Emmanuelle Uro‐Coste and has published in prestigious journals such as Neurology, Annals of Neurology and The American Journal of Surgical Pathology.

In The Last Decade

Fabrice Chrétien

16 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrice Chrétien France 9 138 124 87 82 66 17 371
Lasse Dührsen Germany 16 188 1.4× 160 1.3× 117 1.3× 26 0.3× 71 1.1× 54 626
Kedar Mahajan United States 12 61 0.4× 98 0.8× 24 0.3× 79 1.0× 57 0.9× 24 557
Fredrick A. Boop United States 9 160 1.2× 84 0.7× 61 0.7× 69 0.8× 46 0.7× 13 354
Seiji Ohta Japan 16 105 0.8× 227 1.8× 94 1.1× 37 0.5× 76 1.2× 37 735
Sharon Liu United States 10 128 0.9× 171 1.4× 51 0.6× 260 3.2× 73 1.1× 17 589
Takahiro Iwasawa Japan 6 58 0.4× 52 0.4× 44 0.5× 61 0.7× 23 0.3× 11 336
Monique C.J. Hanse Netherlands 11 202 1.5× 152 1.2× 70 0.8× 15 0.2× 137 2.1× 20 376
Simone Betchen United States 9 71 0.5× 178 1.4× 179 2.1× 25 0.3× 88 1.3× 16 441
Krzysztof Tybor Poland 9 72 0.5× 52 0.4× 52 0.6× 74 0.9× 19 0.3× 23 334
Nobuo Oka Japan 12 70 0.5× 249 2.0× 92 1.1× 21 0.3× 46 0.7× 62 441

Countries citing papers authored by Fabrice Chrétien

Since Specialization
Citations

This map shows the geographic impact of Fabrice Chrétien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Chrétien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Chrétien more than expected).

Fields of papers citing papers by Fabrice Chrétien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Chrétien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Chrétien. The network helps show where Fabrice Chrétien may publish in the future.

Co-authorship network of co-authors of Fabrice Chrétien

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Chrétien. A scholar is included among the top collaborators of Fabrice Chrétien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Chrétien. Fabrice Chrétien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tauziède‐Espariat, Arnault, Samuel Abbou, Alice Métais, et al.. (2024). CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions. Acta Neuropathologica Communications. 12(1). 12–12.
2.
Tauziède‐Espariat, Arnault, Aurore Siegfried, Yvan Nicaise, et al.. (2023). PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors. Acta Neuropathologica. 146(6). 841–844. 4 indexed citations
3.
Moiraghi, Alessandro, Rudy Birsen, Angela Rita Elia, et al.. (2022). Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience. Journal of Neuro-Oncology. 159(2). 347–358. 3 indexed citations
5.
Tauziède‐Espariat, Arnault, Sophie Huybrechts, Émilie Indersie, et al.. (2020). Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis. The American Journal of Surgical Pathology. 45(4). 558–566. 6 indexed citations
6.
Tauziède‐Espariat, Arnault, Fanny Burel‐Vandenbos, Florence Pédeutour, et al.. (2020). Intracranial chondromas: A histopathologic and molecular study of three cases. Clinical Neuropathology. 39(7). 171–178. 1 indexed citations
7.
Gareton, Albane, Gaëlle Pierron, Karima Mokhtari, et al.. (2018). ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review. Journal of Neuropathology & Experimental Neurology. 77(7). 537–541. 32 indexed citations
8.
Ehler, Johannes, Lucinda Barrett, Valerie H. Taylor, et al.. (2017). Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study. Critical Care. 21(1). 262–262. 62 indexed citations
9.
Kuchcinski, Grégory, Charles Mellerio, Johan Pallud, et al.. (2015). Three-tesla functional MR language mapping. Neurology. 84(6). 560–568. 74 indexed citations
10.
Fèvre‐Montange, Michelle, Alexandru Szathmári, Jacques Champier, et al.. (2008). Pineocytoma and Pineal Parenchymal Tumors of Intermediate Differentiation Presenting Cytologic Pleomorphism: A Multicenter Study. Brain Pathology. 18(3). 354–359. 26 indexed citations
11.
Kujas, M., Julie Lejeune, Alexandra Benouaich‐Amiel, et al.. (2005). Chromosome 1p loss: A favorable prognostic factor in low‐grade gliomas. Annals of Neurology. 58(2). 322–326. 69 indexed citations
12.
Chrétien, Fabrice, Gwenaëlle Le Pavec, Emmanuelle Uro‐Coste, et al.. (2004). Expression of Excitatory Amino Acid Transporter-1 (EAAT-1) in Brain Macrophages and Microglia of Patients with Prion Diseases. Journal of Neuropathology & Experimental Neurology. 63(10). 1058–1071. 28 indexed citations
13.
Gray, Françoise, Fabrice Chrétien, & Catherine Keohane. (2001). [Hereditary cerebral amyloid angiopathies].. PubMed. 157(10). 1207–17. 6 indexed citations
14.
Bélec, Laurent, et al.. (1997). [Sequences of human herpes virus type 8 and Epstein-Barr virus in AIDS-related primary central nervous system non-Hodgkin's lymphoma].. PubMed. 45(2-3). 159–63. 3 indexed citations
15.
Hassine, D, et al.. (1995). [Early cerebral lesions in HIV infection. Postmortem radio-pathologic correlations in non-AIDS asymptomatic seropositive patients].. PubMed. 22(3). 148–60. 10 indexed citations
16.
Gray, Françoise, et al.. (1994). Autosomal dominant arteriopathic leuko‐encephalopathy and Alzheimer's disease*. Neuropathology and Applied Neurobiology. 20(1). 22–30. 35 indexed citations
17.
Chrétien, Fabrice, et al.. (1994). [Intramedullary localization of a primary cerebral lymphoma in AIDS].. PubMed. 42(6). 297–303. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026